Beyond Skin Rash: Alpelisib-Induced Anaphylactic Reactions

Alpelisib is a specific oral PI3K inhibitor used combined with fulvestrant for the treatment of patients with HR+/HER2–/PIK3CA-mutated metastatic breast cancer. Adverse drug reactions with alpelisib are common, including hyperglycemia and rash. Here we describe extraordinary and life-threatening rea...

Descripción completa

Detalles Bibliográficos
Autores principales: Schutte, Tim, Zeverijn, Laurien J, Geurts, Birgit S, de Wit, Gijsbrecht F, Kok, Marleen, Opdam, Frans L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322120/
https://www.ncbi.nlm.nih.gov/pubmed/37086483
http://dx.doi.org/10.1093/oncolo/oyad092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322120/
https://www.ncbi.nlm.nih.gov/pubmed/37086483
http://dx.doi.org/10.1093/oncolo/oyad092

Ejemplares similares